APOB and coronary artery disorder: An intriguing finding is the trend toward a stepwise decrease in risk of ischemic heart disease associated with the T allele, which may be attributed to a higher intake of lipid-lowering therapy and possibly due to subtle increases in plasma levels of apolipoprotein B in TT and TC carriers versus CC in the population as a whole.